Cargando…

Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study

OBJECTIVES: The usefulness of telemedicine (TM) in type 2 diabetes mellitus (T2DM) has been discussed in recent years. The aim of this study is to describe patients’ perceptions about TM and to identify preferences on TM resources, in Spain. DESIGN: An observational, cross-sectional study was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Fortúnez, Patricia, Franch-Nadal, Josep, Fornos-Pérez, José A, Martínez-Martínez, Fernando, de Paz, Hector David, Orera-Peña, María Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596977/
https://www.ncbi.nlm.nih.gov/pubmed/31230025
http://dx.doi.org/10.1136/bmjopen-2018-028467
_version_ 1783430527892586496
author Rodríguez-Fortúnez, Patricia
Franch-Nadal, Josep
Fornos-Pérez, José A
Martínez-Martínez, Fernando
de Paz, Hector David
Orera-Peña, María Luisa
author_facet Rodríguez-Fortúnez, Patricia
Franch-Nadal, Josep
Fornos-Pérez, José A
Martínez-Martínez, Fernando
de Paz, Hector David
Orera-Peña, María Luisa
author_sort Rodríguez-Fortúnez, Patricia
collection PubMed
description OBJECTIVES: The usefulness of telemedicine (TM) in type 2 diabetes mellitus (T2DM) has been discussed in recent years. The aim of this study is to describe patients’ perceptions about TM and to identify preferences on TM resources, in Spain. DESIGN: An observational, cross-sectional study was conducted using a structured questionnaire. PARTICIPANTS: 1036 patients with T2DM accepted to participate in the study (response rate: 68%). RESULTS: Blood glucose values were recorded by 85.9% of the patients while data such as lifestyle habits were only recorded by 14.4% of the patients. Previous experience in TM was reported by 9.8% of the patients, out of which 70.5% were satisfied with its service and 73.5% considered that the use of TM had optimised their T2DM management. However, most of these patients noted aspects to be improved such as user-friendliness (81.4%), interaction with the medical team (78.4%) and time required for recording/transferring data (78.4%). Experienced patients had better perception about TM usefulness than naïve patients for all listed aspects (p<0.05). Among naïve patients, 38.2% expressed their willingness to participate in TM programmes, but only 4.7% were invited to do so. Patients considered that physicians’ (77.5%) and pharmacists’ (75.5%) encouragement can boost the use of TM. CONCLUSIONS: In Spain, nearly 10% of patients with T2DM have experience with TM and it is well accepted, especially one based on glucometers. Nevertheless, in order to promote TM use, easier and time-saving programmes for patient-physician interaction should be optimised.
format Online
Article
Text
id pubmed-6596977
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65969772019-07-18 Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study Rodríguez-Fortúnez, Patricia Franch-Nadal, Josep Fornos-Pérez, José A Martínez-Martínez, Fernando de Paz, Hector David Orera-Peña, María Luisa BMJ Open Diabetes and Endocrinology OBJECTIVES: The usefulness of telemedicine (TM) in type 2 diabetes mellitus (T2DM) has been discussed in recent years. The aim of this study is to describe patients’ perceptions about TM and to identify preferences on TM resources, in Spain. DESIGN: An observational, cross-sectional study was conducted using a structured questionnaire. PARTICIPANTS: 1036 patients with T2DM accepted to participate in the study (response rate: 68%). RESULTS: Blood glucose values were recorded by 85.9% of the patients while data such as lifestyle habits were only recorded by 14.4% of the patients. Previous experience in TM was reported by 9.8% of the patients, out of which 70.5% were satisfied with its service and 73.5% considered that the use of TM had optimised their T2DM management. However, most of these patients noted aspects to be improved such as user-friendliness (81.4%), interaction with the medical team (78.4%) and time required for recording/transferring data (78.4%). Experienced patients had better perception about TM usefulness than naïve patients for all listed aspects (p<0.05). Among naïve patients, 38.2% expressed their willingness to participate in TM programmes, but only 4.7% were invited to do so. Patients considered that physicians’ (77.5%) and pharmacists’ (75.5%) encouragement can boost the use of TM. CONCLUSIONS: In Spain, nearly 10% of patients with T2DM have experience with TM and it is well accepted, especially one based on glucometers. Nevertheless, in order to promote TM use, easier and time-saving programmes for patient-physician interaction should be optimised. BMJ Publishing Group 2019-06-22 /pmc/articles/PMC6596977/ /pubmed/31230025 http://dx.doi.org/10.1136/bmjopen-2018-028467 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Rodríguez-Fortúnez, Patricia
Franch-Nadal, Josep
Fornos-Pérez, José A
Martínez-Martínez, Fernando
de Paz, Hector David
Orera-Peña, María Luisa
Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title_full Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title_fullStr Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title_full_unstemmed Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title_short Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study
title_sort cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in spain: patient’s perspective. the enreda2 study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596977/
https://www.ncbi.nlm.nih.gov/pubmed/31230025
http://dx.doi.org/10.1136/bmjopen-2018-028467
work_keys_str_mv AT rodriguezfortunezpatricia crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study
AT franchnadaljosep crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study
AT fornosperezjosea crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study
AT martinezmartinezfernando crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study
AT depazhectordavid crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study
AT orerapenamarialuisa crosssectionalstudyabouttheuseoftelemedicinefortype2diabetesmellitusmanagementinspainpatientsperspectivetheenreda2study